Backlog and Orders - As of December 31, 2025, the backlog of unfilled orders was $53.9 million, an increase from $39.5 million at the same date in 2024[98]. - The company’s backlog may be influenced by customer tendencies to rely on short lead times during periods of low demand[98]. Research and Development - The company spent approximately $9.4 million on engineering and product development in 2025, compared to $8.5 million in 2024, reflecting a year-over-year increase of 10.6%[89]. - The company operates in a competitive environment with competitors having greater financial resources and production capabilities, necessitating ongoing investment in R&D and customer support[95]. - The company’s engineering activities are primarily focused on customized products, which are essential for maintaining competitive advantage[89]. Patents and Certifications - At December 31, 2025, the company held 24 active U.S. patents and had two pending applications, with patents expiring between 2026 and 2039[94]. - The Massachusetts, New York, and Canadian facilities are ISO 9001:2015 certified, ensuring compliance with quality management standards[85]. Workforce and Operations - The company employs approximately 100 engineers for product development and has the capacity to hire temporary third-party consultants when needed[87]. - The company has a total of 407 employees, with 385 being full-time, and has not experienced any work stoppages[99]. - The company’s manufacturing operations are located in the U.S., Canada, and Italy, utilizing both standard components and custom parts[83].

Group 1 - inTEST Corporation (NYSEAM:INTT) is highlighted as one of the best semiconductor equipment stocks to invest in currently [1] - Northland raised the price target for inTEST Corporation to $14 from $10 while maintaining a Market Perform rating after the company reported better-than-expected fiscal Q4 results and provided solid FY26 guidance [2] - The company reported fiscal Q4 2025 results with orders of $37.5 million, driven by strength in Auto/EV and Life Sciences, and a backlog increase of 9.4% sequentially [3][4] Group 2 - Revenue for fiscal Q4 increased by $6.6 million compared to the third quarter, attributed to improved customer capital spending and shipments that were delayed from the previous quarter [4] - inTEST Corporation generates nearly 80% of its revenue from non-semiconductor end markets, indicating a diversified revenue stream [3] - The company provides precision-engineered solutions across various markets, including semiconductors, defense, automotive, aerospace, electronics, fiber optic, telecom, medical, and machining, with operations divided into Thermal Products and Electromechanical Solutions segments [5]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $32.8 million, a 25% increase from $26.2 million in Q3 2025, driven by improved capital spending and new product sales [12][4] - Gross margin expanded to 45.4%, up 350 basis points sequentially from 41.9% in Q3 2025, reflecting higher sales of new products and improved operating leverage [13][14] - Net income for Q4 was $1.2 million, with an adjusted EBITDA of $3.2 million, representing an adjusted EBITDA margin of 9.7% [17][18] Business Line Data and Key Metrics Changes - Revenue increases in Q4 were led by industrial ($3.3 million), defense aerospace ($3.2 million), life sciences ($2.1 million), and auto/EV ($1 million), while semi revenue declined by $2.9 million [12][16] - Life sciences orders tripled sequentially in Q4, reflecting strong bookings for new Alfamation products, while semi orders increased by 18% sequentially [9][10] Market Data and Key Metrics Changes - Non-semi revenues have grown at approximately 20% CAGR over the past five years, indicating successful market diversification [8] - Life sciences orders were up 137% year-over-year, auto EV orders increased by 89%, and industrial orders rose by 53% [9][10] Company Strategy and Development Direction - The company is focused on diversifying its revenue streams, with nearly 80% of Q4 revenue derived from non-semi end markets, aligning with its VISION 2030 goal of generating 25% of revenue from new products [7][25] - The establishment of a manufacturing hub in Malaysia and an expanded European footprint are part of the strategy to enhance customer relationships and capitalize on long-term opportunities [25][26] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for 2026, expecting a gradual recovery in capital spending and a healthy backlog of $53.9 million, with 60% expected to ship beyond Q1 2026 [20][22] - The company anticipates revenue growth of approximately 12% in 2026, driven by diversified demand in industrial, aerospace, defense, auto EV, and life sciences [22][23] Other Important Information - The company reduced total debt by $1.4 million in Q4 and by $7.6 million in 2025, ending the year with approximately $58 million in liquidity [19] - Operating expenses for Q4 were $13.6 million, reflecting a reduction in operating expenses as a percentage of revenue to 41.5% [16] Q&A Session Summary Question: Semi space outlook and guidance - Management indicated that guidance reflects a modest recovery in the semi space, which could be conservative, and they are well positioned to capture growth if it materializes [31] Question: Progress on automotive programs - The automotive sector has shown positive trends, with customers moving forward on 2027 model year programs, and the company is well positioned to support these initiatives [32][34] Question: Strength in life sciences orders - Life sciences have been a bright spot, with significant success in the medtech space, particularly with new products from Alfamation [35][36] Question: Back-end test positioning - The company is well positioned in the back-end test space, with new products broadening the customer base and preparing for growth as investments in testing increase [43] Question: Silicon carbide space outlook - Management is optimistic about the silicon carbide space, expecting growth to return in 2027, with some potential recovery in the second half of 2026 [45][47] Question: Gross margins and future guidance - Management noted that while semi contributes higher margins, the current focus is on maintaining strong margins through operational efficiencies and product mix [53][54] Question: Bookings activity and momentum - The company has seen strong bookings activity, particularly in the automotive sector, and expects healthy order levels moving forward [61][62] Question: Operating expenses and incentive compensation - Management confirmed that guidance includes considerations for reinstating variable compensation as performance improves [64]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $32.8 million, a 25% increase from $26.2 million in Q3 2025, driven by improved capital spending and new product sales [12] - Gross margin expanded to 45.4% in Q4 2025, up from 41.9% in Q3 2025, reflecting higher sales of new products and improved operating leverage [13][14] - Net income for Q4 2025 was $1.2 million, with an adjusted EBITDA of $3.2 million, representing an adjusted EBITDA margin of 9.7% [17] Business Line Data and Key Metrics Changes - Revenue from industrial markets increased by $3.3 million, defense aerospace by $3.2 million, life sciences by $2.1 million, and auto/EV by about $1 million in Q4 2025 [12] - Life sciences orders tripled sequentially in Q4 2025, reflecting strong bookings for new Alfamation products [9] - Semi orders were up about 18% sequentially, but represented only 25% of total orders in Q4 2025, down from 40% in Q4 2024 [10] Market Data and Key Metrics Changes - Non-semi revenues grew at approximately 20% CAGR over the past five years, indicating successful market diversification [8] - Life sciences orders increased by 137% year-over-year, auto EV orders were up 89%, and industrial orders increased by 53% [9] - The backlog at year-end 2025 was $53.9 million, a 36% increase year-over-year, with 60% expected to ship beyond Q1 2026 [10] Company Strategy and Development Direction - The company is focused on revenue diversification and new product innovation as key pillars of its VISION 2030 growth strategy [6][24] - The establishment of a manufacturing hub in Malaysia and an expanded European footprint are aimed at better serving customers and deepening relationships in key regions [24] - The goal is to generate 25% of revenue from new products by 2030, with current trends indicating progress towards this target [25] Management's Comments on Operating Environment and Future Outlook - Management noted that customer hesitation to spend on capital projects was driven by tariff and macroeconomic uncertainties, but demand is expected to recover gradually [4][20] - The company anticipates 2026 will be a year of returning growth, with revenue guidance of $125 million to $130 million, reflecting a 12% increase over 2025 [22] - There is cautious optimism regarding the semiconductor market, with expectations for modest recovery but not heavily relying on it for growth [20][58] Other Important Information - Operating expenses for Q4 2025 were $13.6 million, an increase of $1.4 million sequentially, primarily due to higher sales commissions and marketing activity [16] - The company reduced debt by $1.4 million in Q4 2025, ending the year with approximately $58 million in liquidity [19] Q&A Session Summary Question: Insights on the semiconductor space and guidance - Management indicated that guidance reflects a modest recovery in the semiconductor market, which could be conservative, but they are well-positioned to capture growth if it materializes [28][29] Question: Progress on automotive programs - The automotive sector has shown positive trends, with customers moving forward with 2027 model year programs, and the company is well-positioned to support these initiatives [31] Question: Growth in life sciences - Life sciences have been a bright spot, with significant success in the medtech space, particularly with new products from Alfamation [34][35] Question: Positioning in back-end and front-end semiconductor testing - The company is well-positioned in back-end testing and has launched new products that broaden their customer base, anticipating growth as investments in testing spaces increase [42][43] Question: Guidance on gross margins and potential for improvement - Management acknowledged that while current margins are strong, a recovery in the semiconductor market could lead to further margin improvements, potentially approaching historical levels [54][56] Question: Bookings activity and momentum - The company reported strong bookings activity, particularly in the automotive sector, and expects healthy order levels moving forward [62] Question: Operating expenses and incentive compensation - Management confirmed that guidance includes considerations for reinstating variable compensation and incentives as performance improves [65]

Fourth Quarter & Fiscal Year 2025 Financial Results Conference Call February 27, 2026 Nick Grant, President and CEO Duncan Gilmour, CFO and Treasurer NYSE American: INTT | NYSE American: INTT | Forward-Looking Statements and Key Performance Metrics Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential fut ...

分组1 - inTest Corporation reported quarterly earnings of $0.16 per share, matching the Zacks Consensus Estimate, but down from $0.23 per share a year ago [1] - The company posted revenues of $32.82 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 3.41%, but down from $36.6 million year-over-year [2] - inTest shares have increased approximately 33.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.9% [3] 分组2 - The earnings outlook for inTest is mixed, with the current consensus EPS estimate for the coming quarter at $0.03 on revenues of $28.57 million, and $0.35 on revenues of $122.52 million for the current fiscal year [7] - The Electronics - Measuring Instruments industry, to which inTest belongs, is currently ranked in the top 14% of over 250 Zacks industries, indicating a favorable outlook [8]

Revenue Performance - Q4 2025 revenue was $32.8 million, a decrease of 10.3% compared to Q4 2024, but an increase of 25.1% from Q3 2025[7] - For the full year 2025, revenue declined to $113.8 million, a 12.9% decrease from 2024, primarily due to economic uncertainties affecting capital spending[14] - Total revenue for the twelve months ended December 31, 2025, was $113,825,000, a decrease of 12.9% compared to $130,690,000 in 2024[45] - The consolidated revenue for the three months ended December 31, 2025, was $32,822, a decrease from $36,603 in the same period of 2024[50] Orders and Backlog - Orders for Q4 2025 reached $37.5 million, driven by strong demand in Auto/EV and Life Sciences, representing a 22.2% increase year-over-year[18] - Year-end backlog was $53.9 million, up 36% from December 31, 2024, indicating strong future demand[3] - Fourth quarter orders were $37.5 million, flat sequentially and up $6.8 million, or 22.2%, year-over-year[20] - Backlog as of December 31, 2025, was $53.9 million, a 9.4% increase from September 30, 2025, and a 36.4% increase compared to December 31, 2024[21] - Total orders for the twelve months ended December 31, 2025, increased by 19.0% to $128,221, compared to $107,704 in 2024[48] Profitability and Income - Net income for Q4 2025 was $1.2 million, or $0.10 per diluted share, down 17.4% from the previous year[12] - Adjusted net income (Non-GAAP) for Q4 2025 was $2.0 million, with an adjusted EPS of $0.16, reflecting a 30.4% decrease year-over-year[12] - The company reported a net loss of $2,527,000 for the twelve months ended December 31, 2025, compared to net earnings of $2,891,000 in 2024[43] - Net earnings for Q4 2025 were $1,243,000, a decrease from $1,504,000 in Q4 2024, while the net margin was 3.8% compared to 4.1% in the previous year[55] - Adjusted net earnings for the three months ended December 31, 2025, were $1,953, compared to $2,782 in 2024[54] Margins and Expenses - Gross margin improved to 45.4%, a sequential increase of 350 basis points, attributed to manufacturing efficiency and new product sales[10] - Adjusted EBITDA for Q4 2025 was $3,192,000, down from $4,412,000 in Q4 2024, resulting in an adjusted EBITDA margin of 9.7%, compared to 12.1% in the prior year[55] - Adjusted EBITDA for the twelve months ended December 31, 2025, was $3,950,000, significantly lower than $10,818,000 in 2024, with an adjusted EBITDA margin of 3.5% compared to 8.3% in the prior year[55] - Operating expenses for 2026 are projected to be between $53 million to $55 million, with amortization expense expected to be $2.6 million[23] Cash and Debt Management - Total debt was reduced by $7.6 million during 2025, with total debt at $7.5 million by the end of Q4 2025[16] - The company maintained a strong balance sheet with $18.1 million in cash and cash equivalents at the end of Q4 2025[16] - Cash and cash equivalents decreased to $14,216,000 as of December 31, 2025, down from $19,830,000 at the end of 2024[43] - The company’s total assets as of December 31, 2025, were $151,313,000, slightly down from $152,288,000 in 2024[41] Market Segments and Growth - The Industrial market revenue increased by 208.9% year-over-year, reaching $6,937,000 for the three months ended December 31, 2025[45] - The company reported a significant increase in Life Sciences revenue, which rose by 67.5% year-over-year to $9,047,000 for the twelve months ended December 31, 2025[45] - The Auto/EV segment saw a significant growth of 88.6%, with orders rising to $36,564 from $19,390[48] - Life Sciences orders surged by 137.3%, reaching $10,924 compared to $4,603 in the previous year[48] Future Projections - For Q1 2026, projected revenue is between $31 million to $33 million, with a gross margin of approximately 44%[22] - For the full year 2026, revenue is expected to be between $125 million to $130 million, with a gross margin of approximately 45%[23] - Management anticipates a modest pick-up in demand from Semi customers in the second half of 2026[22] - Approximately 60% of the backlog is expected to ship beyond the first quarter of 2026[21] Strategic Initiatives - The Vision 2030 Strategy focuses on innovation and market diversification, which has achieved a 20% compound annual growth rate over the last five years[5] - The company is executing its VISION 2030 Strategy to increase diversification and scale the business[22] - InTest Corporation's growth strategy includes organic growth and acquisitions to expand market reach and customer penetration[28]

Core Viewpoint - InTest Corporation reported strong financial results for Q4 2025, with significant orders driven by the Auto/EV sector [1] Financial Performance - The company achieved orders of $37.5 million in the fourth quarter of 2025, indicating robust demand from Auto/EV customers [1]

Company Overview - inTest Corporation (INTT) shares increased by 8.9% to close at $8.72, with notable trading volume exceeding typical levels [1] - The stock has gained 8.5% over the past four weeks, driven by record order growth, backlog expansion, and strong demand in the auto/EV and defense sectors [1] Earnings Expectations - The company is projected to report quarterly earnings of $0.16 per share, reflecting a year-over-year decline of 30.4% [2] - Expected revenues are $31.74 million, down 13.3% from the same quarter last year [2] Earnings Estimate Trends - The consensus EPS estimate for inTest has remained unchanged over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [3] - Monitoring inTest's performance is essential to determine if the recent stock price increase can sustain momentum [3] Industry Context - inTest is part of the Zacks Electronics - Measuring Instruments industry, which includes Keysight (KEYS) [4] - Keysight's stock rose by 2.4% to $214.5, with a 5.5% return over the past month, and it has a consensus EPS estimate of $1.99, representing a 9.3% increase year-over-year [5]